PCI Expands U.S. Sterile Manufacturing
PCI Pharma Services announced major U.S. infrastructure investments exceeding $1 billion to expand its sterile fill-finish and drug-device combination capabilities. Plans include high-speed isolator filling lines for prefilled syringes, cartridges and vials, as well as drug-device combination assembly and packaging.